Diagnosis and treatment of premenstrual dysphoric disorder: an update.

  title={Diagnosis and treatment of premenstrual dysphoric disorder: an update.},
  author={Meir Steiner and L. I. van den Born},
  journal={International clinical psychopharmacology},
  volume={15 Suppl 3},
Premenstrual dysphoric disorder (PMDD) appears in the appendix of the DSM-IV under the heading 'depressive disorder not otherwise specified'. Yet, recently, a group of experts reached a consensus that PMDD is a distinct clinical entity with characteristic symptoms of irritability, anger, internal tension, dysphoria, and mood lability. PMDD is the more severe form of premenstrual symptomatology, whereas premenstrual syndrome (PMS) is milder and more prevalent and both must be differentiated from… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 21 extracted citations

Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics • 2011
View 5 Excerpts
Highly Influenced

The correlation between neurosteroids and neurotransmitters with liver yang rising and liver qi stagnation types of premenstrual syndrome.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…